Francesco N. Lauria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Francesco N. Lauria has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Almerico Marruchella
Respiratory Endoscopy Unit, National Institute for Infectious Diseases "L. Spallanzani", Via Portuense 292, 00149 Rome, Italy
1 shared publication - Almerico Marruchella
Health Department (INMI), Italy
1 shared publication - Angela Corpolongo
Clinical Department, National Institute for Infectious Diseases "L. Spallanzani", via Portuense 292, 00149 Rome, Italy
1 shared publication C Angeletti
1 shared publication- Carla Nisii
Microbiology and Biobank Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCS, 00149 Rome, Italy
1 shared publication - Chiara Tommasi
1“Lazzaro Spallanzani” National Institute for Infectious Diseases-IRCCS, Via Portuense 292, Rome, 00149, Italy
1 shared publication
Latest Publications
- 1 October 2010
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 14, S13-S17
Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology
- 1 October 2010
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 14, S13-S17
Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology
- Open Access
- 20 February 2010
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 33
A case of pulmonary tuberculosis presenting as diffuse alveolar haemorrhage: is there a role for anticardiolipin antibodies?
Diffuse alveolar haemorrhage (DAH) has been rarely reported in association with pulmonary infections.
- 20 February 2010
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 33
Open AccessA case of pulmonary tuberculosis presenting as diffuse alveolar haemorrhage: is there a role for anticardiolipin antibodies?
Diffuse alveolar haemorrhage (DAH) has been rarely reported in association with pulmonary infections.
- Open Access
- 21 November 2009
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 182
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
Background: Interferon-gamma (IFN-γ) release assays (IGRAs) were designed to detect latent tuberculosis infection (LTBI). However, discrepancies were found between the tuberculin skin test (TST) and IGRAs results that cannot be attributed to prior Bacille Calmètte Guerin vaccinations. The aim of this study was to evaluate tools for improving LTBI diagnosis by analyzing the IFN-γ response to RD1 proteins in prolonged (long-term response) whole blood tests in those subjects resulting negative to assays such as QuantiFERON-TB Gold In tube (QFT-IT). Methods: The study population included 106 healthy TST+ individuals with suspected LTBI (recent contact of smear-positive TB and homeless) consecutively enrolled. As controls, 13 healthy subjects unexposed to M. tuberculosis (TST-, QFT-IT-) and 29 subjects with cured pulmonary TB were enrolled. IFN-γ whole blood response to RD1 proteins and QFT-IT were evaluated at day 1 post-culture. A prolonged test evaluating long-term IFN-γ response (7-day) to RD1 proteins in diluted whole blood was performed. Results: Among the enrolled TST+ subjects with suspected LTBI, 70/106 (66.0%) responded to QFT-IT and 64/106 (60.3%) to RD1 proteins at day 1. To evaluate whether a prolonged test could improve the detection of LTBI, we set up the test using cured TB patients (with a microbiologically diagnosed past pulmonary disease) who resulted QFT-IT-negative and healthy controls as comparator groups. Using this assay, a statistically significant difference was found between IFN-γ levels in cured TB patients compared to healthy controls (p < 0.006). Based on these data, we constructed a receiver operating characteristic (ROC) curve and we calculated a cut-off. Based on the cut-off value, we found that among the 36 enrolled TST+ subjects with suspected LTBI not responding to QFT-IT, a long term response to RD1 proteins was detected in 11 subjects (30.6%). Conclusion: These results indicate that IFN-γ long-term response to M. tuberculosis RD1 antigens may be used to detect past infection with M. tuberculosis and may help to identify additional individuals with LTBI who resulted negative in the short-term tests. These data may provide useful information for improving immunodiagnostic tests for tuberculosis infection, especially in individuals at high risk for active TB.
- 21 November 2009
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 182
Open AccessNew tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
Background: Interferon-gamma (IFN-γ) release assays (IGRAs) were designed to detect latent tuberculosis infection (LTBI). However, discrepancies were found between the tuberculin skin test (TST) and IGRAs results that cannot be attributed to prior Bacille Calmètte Guerin vaccinations. The aim of this study was to evaluate tools for improving LTBI diagnosis by analyzing the IFN-γ response to RD1 proteins in prolonged (long-term response) whole blood tests in those subjects resulting negative to assays such as QuantiFERON-TB Gold In tube (QFT-IT). Methods: The study population included 106 healthy TST+ individuals with suspected LTBI (recent contact of smear-positive TB and homeless) consecutively enrolled. As controls, 13 healthy subjects unexposed to M. tuberculosis (TST-, QFT-IT-) and 29 subjects with cured pulmonary TB were enrolled. IFN-γ whole blood response to RD1 proteins and QFT-IT were evaluated at day 1 post-culture. A prolonged test evaluating long-term IFN-γ response (7-day) to RD1 proteins in diluted whole blood was performed. Results: Among the enrolled TST+ subjects with suspected LTBI, 70/106 (66.0%) responded to QFT-IT and 64/106 (60.3%) to RD1 proteins at day 1. To evaluate whether a prolonged test could improve the detection of LTBI, we set up the test using cured TB patients (with a microbiologically diagnosed past pulmonary disease) who resulted QFT-IT-negative and healthy controls as comparator groups. Using this assay, a statistically significant difference was found between IFN-γ levels in cured TB patients compared to healthy controls (p < 0.006). Based on these data, we constructed a receiver operating characteristic (ROC) curve and we calculated a cut-off. Based on the cut-off value, we found that among the 36 enrolled TST+ subjects with suspected LTBI not responding to QFT-IT, a long term response to RD1 proteins was detected in 11 subjects (30.6%). Conclusion: These results indicate that IFN-γ long-term response to M. tuberculosis RD1 antigens may be used to detect past infection with M. tuberculosis and may help to identify additional individuals with LTBI who resulted negative in the short-term tests. These data may provide useful information for improving immunodiagnostic tests for tuberculosis infection, especially in individuals at high risk for active TB.
- Open Access
- 8 April 2009
- Published by Springer Nature in BMC Medicine
- Vol. 7 (1) , 15
Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007
Hepatitis B outbreaks in healthcare settings are still a serious public health concern in high-income countries. To elucidate the most frequent infection pathways and clinical settings involved, we performed a systematic review of hepatitis B virus outbreaks published between 1992 and 2007 within the EU and USA.
- 8 April 2009
- Published by Springer Nature in BMC Medicine
- Vol. 7 (1) , 15
Open AccessPatient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007
Hepatitis B outbreaks in healthcare settings are still a serious public health concern in high-income countries. To elucidate the most frequent infection pathways and clinical settings involved, we performed a systematic review of hepatitis B virus outbreaks published between 1992 and 2007 within the EU and USA.
- 1 December 2003
- p. 35-43
The impact of nosocomial infections on hospital care costs.
Estimating costs due to nosocomial infection (NI) requires the incremental costs associated with NI diagnosis and treatment must be distinguished from those attributable to the management of the original healthcare problems. We carried out a review of the analyses of additional costs resulting from NIs and the evaluation of the methods used to estimate these costs, in order to perform a cost benefit analysis of NI prevention activities. Characteristics of additional costs for main NIs were initially considered. Secondly, a review of methods for estimating the incremental costs was performed. Finally, a cost effectiveness analysis of NI prevention activities was performed. Few studies estimated the incidence of NLs and assessed the economic burden they cause. Investigators generally estimated only direct additional costs. Implicit physician assessment, unmatched group comparison, matched control and appropriateness evaluation protocol (AEP)-based methods are the methodologies used to estimate incremental days of stay due to NIs. Different studies show possible benefits, in terms of health and cost savings, when hospital-acquired infections are prevented. However, there is a need for further studies to evaluate in greater detail the variables related to costs attributable to these infections and to enhance the control strategies. Moreover, a structured surveillance and control program of NI is the single most effective tool for prevention.
- 1 December 2003
- p. 35-43
The impact of nosocomial infections on hospital care costs.
Estimating costs due to nosocomial infection (NI) requires the incremental costs associated with NI diagnosis and treatment must be distinguished from those attributable to the management of the original healthcare problems. We carried out a review of the analyses of additional costs resulting from NIs and the evaluation of the methods used to estimate these costs, in order to perform a cost benefit analysis of NI prevention activities. Characteristics of additional costs for main NIs were initially considered. Secondly, a review of methods for estimating the incremental costs was performed. Finally, a cost effectiveness analysis of NI prevention activities was performed. Few studies estimated the incidence of NLs and assessed the economic burden they cause. Investigators generally estimated only direct additional costs. Implicit physician assessment, unmatched group comparison, matched control and appropriateness evaluation protocol (AEP)-based methods are the methodologies used to estimate incremental days of stay due to NIs. Different studies show possible benefits, in terms of health and cost savings, when hospital-acquired infections are prevented. However, there is a need for further studies to evaluate in greater detail the variables related to costs attributable to these infections and to enhance the control strategies. Moreover, a structured surveillance and control program of NI is the single most effective tool for prevention.